| Year | Q2 2024 | Q1 2024 |
|---|---|---|
| Total Revenue | 1.46B | 1.42B |
| Cost of Revenue | 900.24M | 949.99M |
| Gross Profit | 557.04M | 469.01M |
| Operating Expenses | 557.04M | 138.96M |
| Research and Development | 0 | 0 |
| Selling, General & Administrative Expenses | 0 | 138.96M |
| Selling & Marketing Expenses | 0 | 0 |
| General & Administrative Expenses | 0 | 0 |
| Other Expenses | 557.04M | 0 |
| Operating Income | 340.2M | 330.05M |
| Total Other Income/Expenses Net | 66.85M | 46.29M |
| Income Before Tax | 407.05M | 376.34M |
| Income Tax | 86.37M | 84.57M |
| Net Income | 318.54M | 287.51M |
| Basic EPS | 2.8 | 2.56 |
| EPS Diluted | 2.8 | 2.56 |
| Basic Average Shares | 113.76M | 112.31M |
| Diluted Average Shares | 113.76M | 112.31M |
| EBITDA | 432.92M | 401.29M |
Fineotex Chemical Limited
FCL.NS
NSE
227.57INR9.07 (3.70%)
FCL.NS Financial Statements
Retained Earning Schedule
| Year |
|---|
| Retained Earnings (Previous Year) |
| Net Income |
| Stock Repurchases |
| Dividend Paid |
| Retained Earnings |
| Other Distributions |
PPE Schedule
| Year |
|---|
| Gross PPE |
| Annual Depreciation |
| Capital Expenditure |
| Net PPE |
Intangible and Goodwill Schedule
| Year |
|---|
| Acquisitions and Adjustments |
| Goodwill (Previous Year) |
| Goodwill |